Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma

Abstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, a...

Full description

Bibliographic Details
Main Authors: Huiyong Wu, Wei Zhao, Jianbo Zhang, Jianjun Han, Shuguang Liu
Format: Article
Language:English
Published: BMC 2018-11-01
Series:BMC Gastroenterology
Subjects:
Online Access:http://link.springer.com/article/10.1186/s12876-018-0899-3
id doaj-2ac86a68872443da9615e125d1867576
record_format Article
spelling doaj-2ac86a68872443da9615e125d18675762020-11-25T02:36:41ZengBMCBMC Gastroenterology1471-230X2018-11-011811610.1186/s12876-018-0899-3Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinomaHuiyong Wu0Wei Zhao1Jianbo Zhang2Jianjun Han3Shuguang Liu4Department of Intervention, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Radiotherapy, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of pathology, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Intervention, Shandong Tumor Hospital Affiliated to Shandong UniversityDepartment of Thoracic Oncology Surgery, Shandong Tumor Hospital Affiliated to Shandong UniversityAbstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, as it may impact the treatment strategy of the patients. In the present study, we described the imaging findings of the HCC associated A-P shunts and discussed the treatments strategy of such patients. From the findings, we also discussed the potential cause of A-P shunts. Methods Clinical data of HCC patients (n = 560), admitted to the hospital between April 2012 to April 2014, were reviewed. Hepatic angiography was used to examine the presence of A-P shunts. Of the 137 patients with A-P shunts, grading of the A-P shunts was performed, and statistical analysis of the different grades of A-P shunts and clinical characteristics was performed. Results The hepatic angiography confirmed that 99 patients had typical A-P shunts (Grade 1–3), and 38 patients had atypical A-P shunts. Embolization was the main strategy used to treat A-P shunts, in which liquid embolic agents appeared to provide a better treatment outcome. The correlation analysis showed that the grading of portal vein tumor thrombus was significantly associated with the grading of A-P shunt (p = < 0.001, Spearman correlation coefficient was 0.816 ± 0.043). Conclusions We characterized A-P shunts and proposed treatment strategy for treating HCC patients with various levels of A-P shunts. The findings supported the hypothesis that the formation of HCC associated A-P shunts was caused by tumor thrombus.http://link.springer.com/article/10.1186/s12876-018-0899-3Hepatocellular carcinomaHepatic arterioportal shuntsPortal vein tumor embolusTransarterial chemoembolization
collection DOAJ
language English
format Article
sources DOAJ
author Huiyong Wu
Wei Zhao
Jianbo Zhang
Jianjun Han
Shuguang Liu
spellingShingle Huiyong Wu
Wei Zhao
Jianbo Zhang
Jianjun Han
Shuguang Liu
Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
BMC Gastroenterology
Hepatocellular carcinoma
Hepatic arterioportal shunts
Portal vein tumor embolus
Transarterial chemoembolization
author_facet Huiyong Wu
Wei Zhao
Jianbo Zhang
Jianjun Han
Shuguang Liu
author_sort Huiyong Wu
title Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
title_short Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
title_full Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
title_fullStr Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
title_full_unstemmed Clinical characteristics of hepatic Arterioportal shunts associated with hepatocellular carcinoma
title_sort clinical characteristics of hepatic arterioportal shunts associated with hepatocellular carcinoma
publisher BMC
series BMC Gastroenterology
issn 1471-230X
publishDate 2018-11-01
description Abstract Background Hepatic arterioportal shunt (A-P shunt) is defined as the direct blood flow established between hepatic artery and portal venous system; it is frequently observed in patients with hepatocellular carcinoma (HCC). Clinically, it is important to diagnose HCC associated A-P shunts, as it may impact the treatment strategy of the patients. In the present study, we described the imaging findings of the HCC associated A-P shunts and discussed the treatments strategy of such patients. From the findings, we also discussed the potential cause of A-P shunts. Methods Clinical data of HCC patients (n = 560), admitted to the hospital between April 2012 to April 2014, were reviewed. Hepatic angiography was used to examine the presence of A-P shunts. Of the 137 patients with A-P shunts, grading of the A-P shunts was performed, and statistical analysis of the different grades of A-P shunts and clinical characteristics was performed. Results The hepatic angiography confirmed that 99 patients had typical A-P shunts (Grade 1–3), and 38 patients had atypical A-P shunts. Embolization was the main strategy used to treat A-P shunts, in which liquid embolic agents appeared to provide a better treatment outcome. The correlation analysis showed that the grading of portal vein tumor thrombus was significantly associated with the grading of A-P shunt (p = < 0.001, Spearman correlation coefficient was 0.816 ± 0.043). Conclusions We characterized A-P shunts and proposed treatment strategy for treating HCC patients with various levels of A-P shunts. The findings supported the hypothesis that the formation of HCC associated A-P shunts was caused by tumor thrombus.
topic Hepatocellular carcinoma
Hepatic arterioportal shunts
Portal vein tumor embolus
Transarterial chemoembolization
url http://link.springer.com/article/10.1186/s12876-018-0899-3
work_keys_str_mv AT huiyongwu clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma
AT weizhao clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma
AT jianbozhang clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma
AT jianjunhan clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma
AT shuguangliu clinicalcharacteristicsofhepaticarterioportalshuntsassociatedwithhepatocellularcarcinoma
_version_ 1724798645225652224